Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "adolescent"

163 News Found

Women’s hospital opens in Delhi with $5 million backing
Hospitals | May 18, 2026

Women’s hospital opens in Delhi with $5 million backing

30,000 sq. ft. multispeciality facility aims to deliver integrated care for women across every life stage


Lilly and UNICEF launch $50M push to reach 30 million children with life-saving health care
News | May 15, 2026

Lilly and UNICEF launch $50M push to reach 30 million children with life-saving health care

The target reach is of more than 30 million young people and caregivers across 21 countries


Pfizer scores landmark EU approval for  hemophilia drug HYMPAVZI
Drug Approval | May 14, 2026

Pfizer scores landmark EU approval for hemophilia drug HYMPAVZI

The decision marks a significant expansion for Pfizer’s once-weekly injectable therapy


AbbVie seeks FDA nod for RINVOQ use in severe alopecia areata
Drug Approval | April 29, 2026

AbbVie seeks FDA nod for RINVOQ use in severe alopecia areata

After Phase 3 results show major hair regrowth gains


Novo Nordisk posts strong late-stage results for oral diabetes pill in children and teens
Clinical Trials | April 24, 2026

Novo Nordisk posts strong late-stage results for oral diabetes pill in children and teens

The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c


ENSPRYNG cuts MOGAD relapse risk by 68% in landmark Phase III trial: Roche
Clinical Trials | April 22, 2026

ENSPRYNG cuts MOGAD relapse risk by 68% in landmark Phase III trial: Roche

The Phase III METEOROID study met its primary endpoint, with ENSPRYNG cutting the risk of a first relapse by 68% compared to placebo in adults and adolescents


Novo Nordisk’s Etavopivat delivers major Phase 3 win in sickle cell disease
Clinical Trials | April 22, 2026

Novo Nordisk’s Etavopivat delivers major Phase 3 win in sickle cell disease

By cutting pain crises & boosting haemoglobin


Energy drinks emerging as hidden driver of liver damage in India’s youth, warn experts
Healthcare | April 20, 2026

Energy drinks emerging as hidden driver of liver damage in India’s youth, warn experts

Medical experts point to a growing body of research linking energy drinks to liver injury


Briefs: Indoco Remedies and Panacea Biotec
News | April 14, 2026

Briefs: Indoco Remedies and Panacea Biotec

Panacea Biotec receives LoA from CMSS


Vedanta’s community healthcare programmes reach 30 lakh people, FY26 spend crosses Rs 50 crore
News | April 07, 2026

Vedanta’s community healthcare programmes reach 30 lakh people, FY26 spend crosses Rs 50 crore

The last-mile healthcare delivery across 1,100 villages, with focus on maternal health, diagnostics, and chronic disease management